A Phase 4 interventional study of latanoprost 0.005% and Fotil in Open-Angle Glaucoma and Ocular Hypertension, sponsored by Pharmaceutical Research Network. Completed at 5 sites in Poland. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2007-10-24.
Sponsored by Pharmaceutical Research Network · Phase 4, Interventional, and Treatment
To compare the intraocular pressure effect and safety of latanoprost 0.005% given every evening versus PTFC given twice daily.
943 studies on the registry are indexed under Glaucoma, Open-Angle; 118 are open to participants now.
This study's planned enrollment of 36 is below the median of 80 across 710 interventional studies indexed under Glaucoma, Open-Angle.
Browse Glaucoma, Open-Angle studies →Pharmaceutical Research Network is the lead sponsor of 6 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
This study is completed, as verified in Oct 2007. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Latanoprost
Pharmaceutical Research Network